Louisiana HB 870: INSURANCE/HEALTH: Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (REF NO IMPACT See Note)

Status: Conference Committee report received. Lies over under the rules. (as of 2026-05-29)

State: Louisiana · Session: 2026 · Bill: HB 870

Sponsors: Christopher Turner

View Louisiana HB 870 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.